Skip to main content
Heritage Bio Labs · Research use only
Heritage Bio Labs

Research Library

GLP-1 SEMA research

6 articles to explore, with links to 7 original sources.

About GLP-1 SEMA

GLP-1 SEMA is the catalog name for semaglutide, a peptide analogue used in GLP-1 receptor research.

Explore study findings

  • What three semaglutide trials tell us about kidney outcomes

    Semaglutide is a modified peptide that activates the glucagon-like peptide-1, or GLP-1, receptor. It is used in several approved formulations for specific conditions.

    2 sources (2026)

  • What BARI-STEP found after bariatric surgery

    Semaglutide is a modified GLP-1 receptor agonist peptide. In the 2026 BARI-STEP trial, researchers tested whether it affected body weight in adults who had lost less weight than the study’s threshold after bariatric surgery.

    2 sources (2026)

  • What two Alzheimer’s trials found about oral semaglutide

    Semaglutide is a modified GLP-1 receptor agonist. Researchers investigated whether its oral form could slow progression in people with early symptomatic Alzheimer’s disease. Two phase 3 trials reported in 2026 compared it with placebo.

    2 sources (2026)

Check methods and identity

  • Why an alcohol study measured craving and drinking separately

    Semaglutide is a GLP-1 receptor agonist with approved uses for specified metabolic and cardiovascular indications, depending on the product. In a 2026 trial, researchers investigated a different question.

    2 sources (2026)

  • What a noninvasive liver score measured in the SAMARA trial

    Semaglutide is a modified peptide that activates the GLP-1 receptor. The SAMARA study, published in 2026, asked whether noninvasive tests could detect a change in adults with suspected at-risk metabolic dysfunction-associated steatohepatitis, or MASH, who were assigned to semaglutide or placebo.

    2 sources (2026)

Interpret the evidence

Articles from the Heritage Bio Labs research series, with links to the original sources. For research use only; not medical advice.